About us
What we do?
wecare develop dermatological products that bring relief for patients going through extreme situations - such as cancer treatment - that are suffering with mucocutaneous lesions caused by chemotherapy and radiotherapy treatments; helping them to remain in treatment and reduce their discomfort.
Our goal is to improve patients' quality of life and help them to continue in their treatment, increasing the chances of success.
wecare products are specifically developed to meet these patients' needs, having scientific efficacy proven through clinical studies. To this date, wecare have helped over 55.000 patients. .
wecare BRASIL
How wecare was created
wecare started as a small business in Brazil, as we noticed the difficult routine of doctors and nurses, to offer a better experience to their patients, which often abandoned the treatment due to the collateral effects of chemo and radiotherapy.
Facing this challenge, we decided to develop products specially formulated to supply this demand, together with high qualified healthcare professionals.
wecare is in a constantly co-creating process, as company, and we wish that we can inspire others on the pursue of evolvement.
wecare EUROPE
Expansion beyond borders
Aiming to expand accessibility of our products to a greater number of patients, in 2024 wecare joined forces with Promederm SAGL introducing our range of products to the European and Swiss markets.
wecare EUROPE has now two addresses to cover distribution in the continent.
One is located in canton Ticino, in the heart of Switzerland and the other in Seillans, France and we are settling partnerships and collaborations with many research and development institutions.
